Our manuscript describing the cancerhallmarks.com project reached highly cited status in Web of Science database:

Menyhart O, Győrffy B: Multiplicity corrections in life sciences: challenges and consequences, International Journal of Epidemiology (2025)

Menyhart O, Kothalawala WJ, Győrffy B: A gene set enrichment analysis for the cancer hallmarks, Journal of Pharmaceutical Analysis (2025)

Fekete JT, and Győrffy B: MetaAnalysisOnline.com: an Online Tool for the Rapid Meta-Analysis of Clinical and Epidemiological Studies. J Med Internet Res (2025)

Munkácsy G, Santarpia L, and Győrffy B: Immune Signatures Display Subtype-Specific Activation in Breast Cancer, The Oncologist (2025)

Kovács SA, Győrffy B, et al. Unlocking the power of immune checkpoint inhibitors: targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma, Brit J Pharmacol (2025)

Müller D and Győrffy B: EpigenPlot: An interactive web platform for DNA methylation-based biomarker and drug target discovery in colorectal cancer, Br J Pharmacol. (2025)

Murmu A & Győrffy B: Artificial intelligence methods available for cancer research, Front Med (2024)

Our Acta Pharmacologica Sinica paper describing the discovery of new immunotherapy-specific biomarkers has reached highly cited status in the Web of Science.

We have released our new online platform developed to determine the advantage of chemotherapy in breast cancer by using AI methods and clinico-pathological data